Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

331 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 331 results

Early research (Phase 1)Study completedNCT03179332
What this trial is testing

A Trial to Evaluate the Pharmacokinetic and Pharmacodynamic Properties of BioChaperone® Insulin Lispro, Fiasp® and NovoRapid® Delivered by an Insulin Pump

Who this might be right for
Type1 Diabetes Mellitus
Adocia 43
Early research (Phase 1)Study completedNCT01530048
What this trial is testing

Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL)

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 34
Not applicableStudy completedNCT02230618
What this trial is testing

Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 1,029
Large-scale testing (Phase 3)Study completedNCT00600626
What this trial is testing

Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Not applicableStudy completedNCT00920725
What this trial is testing

Subcutaneous Aspart Insulin to Treat Diabetic Ketoacidosis (DKA) and Beta-Hydroxybutyrate Testing in DKA

Who this might be right for
Diabetic Ketoacidosis
Rush University Medical Center 50
Not applicableStudy completedNCT00699179
What this trial is testing

Observational Study to Evaluate the Efficacy and Safety of NovoMix® 30 in Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,308
Large-scale testing (Phase 3)Study completedNCT01467323
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 303
Early research (Phase 1)Study completedNCT00513643
What this trial is testing

Metabolic Effect of Insulin Aspart and Human Insulin in Different Doses

Who this might be right for
Diabetes Mellitus
Profil Institut für Stoffwechselforschung GmbH 16
Large-scale testing (Phase 3)Study completedNCT02670915
What this trial is testing

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Children and Adolescents With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 834
Post-approval studies (Phase 4)Study completedNCT00807092
What this trial is testing

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 145
Large-scale testing (Phase 3)Study completedNCT00447382
What this trial is testing

Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 330
Post-approval studies (Phase 4)Study completedNCT01293396
What this trial is testing

Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids

Who this might be right for
Type 2 Diabetes
Medical University of Graz 20
Post-approval studies (Phase 4)Study completedNCT00591227
What this trial is testing

Management of Diabetes in the Emergency Room: a Randomized Trial of an Insulin Protocol.

Who this might be right for
Type 2 Diabetes Mellitus
Rush University Medical Center 176
Large-scale testing (Phase 3)Ended earlyNCT00500240
What this trial is testing

Effect of Tight Control of Blood Glucose During Hyper-CVAD Chemotherapy For Acute Lymphocytic Leukemia (ALL)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 52
Large-scale testing (Phase 3)Study completedNCT00097279
What this trial is testing

Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 230
Not applicableEnded earlyNCT00206206
What this trial is testing

Evaluation of an ICU Hyperglycemia Protocol Using Insulin Aspart

Who this might be right for
Hyperglycemia
Atlantic Health System 235
Early research (Phase 1)Study completedNCT01620333
What this trial is testing

Pharmacokinetics of Biphasic Insulin Aspart 50 and 70 in Japanese Healthy Volunteers

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 24
Post-approval studies (Phase 4)Study completedNCT00469092
What this trial is testing

Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 480
Early research (Phase 1)Study completedNCT01620437
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Japanese Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Large-scale testing (Phase 3)Ended earlyNCT00267683
What this trial is testing

Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 9
Next Page